Manufacturing

May 22, 2018
By BioPharm International Editors
The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
May 17, 2018
By BioPharm International Editors
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
May 16, 2018
By BioPharm International Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
May 10, 2018
By BioPharm International Editors
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
May 09, 2018
By BioPharm International Editors
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 09, 2018
By BioPharm International Editors
InstantGMP INV is a validated software for real-time material tracking and inventory control in biopharmaceutical manufacturing.
May 07, 2018
By BioPharm International Editors
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
May 04, 2018
By BioPharm International Editors
GE Healthcare’s new Sefia S-2000 cell processing system allows operators to conduct multiple cell therapy manufacturing steps with one instrument.
May 03, 2018
By BioPharm International Editors
The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.
May 03, 2018
By BioPharm International Editors
The company will invest EUR 325 million (US$389 million) in a new biomanufacturing facility in Ireland using single-use bioreactors.
native1_300x100
lorem ipsum